Clinical Trials Browser

OTHER × Pharmacogenomic Variants × 30 days × Clear all

NCT01165333 2026-03-16

CILENT

Phase 1 Completed

Diffuse Intrinsic Pontine Glioma, Glioma

NCT03506373 2026-03-05

Ibrutinib and Ixazomib Citrate in Treating Newly Diagnosed, Relapsed or Refractory Waldenstrom Macroglobulinemia

Phase 2 Terminated

21 enrolled 11 charts

Waldenstrom Macroglobulinemia